ArticleThe British journal of ophthalmology2023
Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma.
Jacob Sterling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled itcites it